Clinical Trial Update: Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effects of N-acetylcysteine during primary percutaneous coronary intervention in ST-segment elevation myocardial infarctio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Suleyman Demirel University | Conditions: Acute ST Segment Elevation Myocardial Infarction | Phase 3 | Status: ACTIVE_NOT_RECRUITING